Active oligonucleotides incorporating alkylating an agent as potential sequence- and base selective modifier of gene expression

Author： Sasaki S.  

Publisher： Elsevier

ISSN： 0928-0987

Source： European Journal of Pharmaceutical Sciences, Vol.13, Iss.1, 2001-04, pp. : 43-51

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Oligonucleotides for upregulating gene expression

By Khorkova Olga   Hsiao Jane   Wahlestedt Claes  

Pharmaceutical Patent Analyst, Vol. 2, Iss. 2, 2013-03 ,pp. : 215-229

Future Science

Access to resources Recommend Favorite

Radiolabelled Oligonucleotides for Imaging of Gene Expression with PET

By  

Current Medicinal Chemistry, Vol. 16, Iss. 33, 2009-11 ,pp. : 4445-4461

Bentham Science Publishers

Access to resources Recommend Favorite

Gene Therapy with Transcription Factor Decoy Oligonucleotides as a Potential Treatment for Cardiovascular Diseases

By  

Current Drug Targets, Vol. 4, Iss. 4, 2003-05 ,pp. : 339-346

Bentham Science Publishers

Access to resources Recommend Favorite

Regulatory sequence analysis: application to the interpretation of gene expression

By Vilo J.   Kivinen K.  

European Neuropsychopharmacology, Vol. 11, Iss. 6, 2001-12 ,pp. : 399-411

Elsevier

Access to resources Recommend Favorite

Triplex-Forming Oligonucleotides - Sequence-Specific DNA Ligands as Tools for Gene Inhibition and for Modulation of DNA-Associated Functions

By  

Current Drug Targets, Vol. 5, Iss. 8, 2004-11 ,pp. : 691-703

Bentham Science Publishers

Access to resources Recommend Favorite